Resident Reporter-March 2013

The hematology/oncology residency is typically a focused experience in which the trainees work to enrich their hematology/oncology knowledge and enhance their clinical skills.
Dr J. Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain, presented “Molecular Insights and Treatment Outlook for GU Malignancies.”1 Cabazitaxel, a taxane derivative targeting microtubules, has proven efficacy in castrate-resistant prostate cancer (CRPC) for which docetaxel has failed.

Results 1 - 2 of 2